ProCE Banner Activity

Changes in the HIV Prevention Landscape and Implications for Australia: Insights From HIVR4P

Conference Coverage
Clinical Thought

Australia has yet to include long-acting injectables in its HIV prevention strategy, but insights from the 5th HIVR4P Conference highlight global experiences and solutions can guide successful implementation.

Released: November 20, 2024

Expiration: November 19, 2025

Share

Provided by

Provided by Clinical Care Options, LLC in partnership with the International AIDS Society  

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Partners

IAS

ProCE Banner

Disclosure

Primary Author

Sharon R. Lewin, AO, FRACP, PhD, FAA, FAHMS

Director, Doherty Institute
Melbourne Laureate Professor
Director, Cumming Global Centre for Pandemic Therapeutics
Head, Department of Infectious Diseases
The University of Melbourne
Melbourne, Australia

Sharon R. Lewin, AO, FRACP, PhD, FAA, FAHMS: consultant/advisor/speaker: AbbVie, Esfam, Gilead.